U.S. and Europe biopharma company transaction volume 2019

In 2015, the total transaction volume of biopharma company trade sales reached its highest point at 214 billion U.S. dollars. This statistic shows the transaction volume of U.S. and European biopharma company trade sales from 2009 to 2019. Please note that the AbbVie/Allergan deal (not completed as of publication date) is not included in 2019.

Transaction volume of U.S. and European biopharma company trade sales from 2009 to 2019 (in billion U.S. dollars)

Characteristic	Transaction volume in billion U.S. dollars
2019*	134
2018	126
2017	68
2016	92
2015	214
2014	88
2013	53
2012	50
2011	69
2010	70
2009	181

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2020

More information

Region

Europe, United States

Survey time period

2009 to 2019

Supplementary notes

Completed and in 2019 announced trade sales of public and private U.S. and European biopharma companies, not including asset deals or purchase of divisions. Transaction volume including contingent payments. European numbers include Israel.
* Does not include 63 billion U.S. dollar sale not yet completed between AbbVie and Allergen.

Citation formats